Where is the live CopyMark page for USPTO serial 75272890?

The live record is at https://getcopymark.com/trademark/75272890. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns CANCER THERAPEUTICS?

According to the public USPTO record for serial number 75272890, the listed owner(s) include: WAVERLY, INC., WAVERLY, INC..

What is USPTO serial number 75272890?

Serial number 75272890 is the USPTO application identifier for the mark CANCER THERAPEUTICS. It is used to track examination, publication, and registration of this trademark.

What is the current status of CANCER THERAPEUTICS?

CANCER THERAPEUTICS (75272890) currently shows USPTO status code 713 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover CANCER THERAPEUTICS?

The public record lists International Classes: 016. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: CANCER THERAPEUTICS Serial# 75272890 | status 713; last event C18. | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CANCER THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

WAVERLY, INC.
Baltimore, MD
Other trademarks owned by WAVERLY, INC.
WAVERLY, INC.
Baltimore, MD
Other trademarks owned by WAVERLY, INC.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JAMES E SHLESINGER

WAVERLY, INC351 W CAMDEN STBALTIMORE, MD 21202-2436UNITED STATES

Goods and services

Class	Description	Status	First use
016	journals published periodically in the field of medicine	SECTION 18 - CANCELLED	Apr 21, 1998

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
May 24, 2001	C18.	CANCELLED SECTION 18-TOTAL	—
May 10, 2001	CANT	CANCELLATION TERMINATED NO. 999999	—
May 10, 2001	CANG	CANCELLATION GRANTED NO. 999999	—
Oct 26, 2000	PETC	CANCELLATION INSTITUTED NO. 999999	—
Feb 9, 1999	R.SR	REGISTERED-SUPPLEMENTAL REGISTER	Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Dec 3, 1998	CNTA	APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER	—
Dec 3, 1998	IUAA	USE AMENDMENT ACCEPTED	—
Nov 12, 1998	AUPC	AMENDMENT TO USE PROCESSING COMPLETE	—
Oct 13, 1998	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 13, 1998	IUAF	USE AMENDMENT FILED	—
Apr 24, 1998	CNFR	FINAL REFUSAL MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 12, 1997	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 1997	DOCK	ASSIGNED TO EXAMINER	—

CANCER THERAPEUTICS